Navigation Links
Eye could reveal serious health disorder

Our eyes could reveal the status of our health and help doctors predict if we have any life threatening disease.//

Conventional vision tests reveal eyesight abnormalities, such as macular degeneration.

But according to professor Emanuel Rosen, of Rosen Eye Associates, Manchester, a test of retina can identify early signs of conditions such as heart disease, cancer and diabetes, thanks to its superior image, reported online edition of Daily Mail.

The new eye test by an upgraded 'ophthalmoscope' a traditional instrument used to examine the retina and vitreous takes only three minutes and can help doctors diagnose life-threatening disease, it said.

The eye is very much an early warning post since its blood vessels allow us to see a mini-version of the body's circulatory system before the patient experiences symptoms, explained professor Rosen.

For example, if there are narrow arteries in the eye's blood vessels, it is likely that person has thinning arteries elsewhere, Rosen said. Many other potentially fatal diseases can be first detected in the eye.

Leukaemia can start with a small haemorrhage in the eye, leading to leaking blood vessels. This symptom is also linked to diabetes, which, if untreated, can lead to blindness.

A swelling of the optic nerve and splashes of blood on the retina may be an early warning of a brain tumor. A swollen, pale optic nerve could be a symptom of multiple sclerosis. And high blood pressure will cause blood vessels to burst and haemorrhages to form in the retina.

Professor Rosen's patients have included a woman whose breast cancer was diagnosed after he had examined her eyes. The test revealed swollen areas at the back of the eye, a sign of secondary cancer tumors.

The retina is the light-sensitive part of the eye on which images are produced. Along with the optic nerve, it is linked to the brain and is therefore part of the ce
'"/>




Page: 1 2

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Beware of the oral patch! It could be cancer!!!
3. Prozac miracle could end in disaster
4. Wonder drug - could end in disaster
5. Pollution could be a risk
6. Fright could be more harmful
7. Pregnant smokers could harm their child
8. Snoring could be a warning
9. Anthrax drug doxycycline could stunt fetal growth
10. Hike in drug licence fee could hit several SSI units in TN
11. Lengthy Fingers could predict heart attacks
Post Your Comments:
(Date:10/10/2008)..., Oct. 10 /PRNewswire/ -- A senior citizen,soared ...ns in a small,plane. The high-flying adventure was...thrill came from a last-wish program through Silve...iving, where Heden was a patient.,Called Go Wish, ... helped,many realize a special activity at the end...
(Date:10/10/2008)...careful screening for these patients, researcher s... -- Patients coping with metabolic syndrome have a...cancer sometime in their lives, a new study sugges...f three or four diseases, that together can porten...ng a number of cancers," said study co-author Dr. ...
(Date:10/10/2008)...er (BMC) has received a $5,807,469 grant over five...to fund the Boston Claude D. Pepper Older American...of only 11 Pepper Centers in the country. , The...ter Program was established in honor of Claude D. ... his five decades of public service, Pepper was an...
(Date:10/10/2008)...ire/ -- A nationally recognized faculty will,prese...ts with breast,cancer in the multimedia course "Op...iomarkers to Treatment Selection" during National ... for practicing oncologists and other interested,h...est patient care,advances. This accredited course ...
Breaking Medicine News(10 mins):Health News:Deck of Cards is More Than a Game: Integral in Silverado Hospice Care 2Health News:Metabolic Syndrome Raises Colon Cancer Risk 75% 2Health News:Metabolic Syndrome Raises Colon Cancer Risk 75% 3Health News:Boston Medical Center receives $5.8m grant 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...on called contact dermatitis may benefit from ridd... tomatoes, according to the results of a small stu...ce inflamed, red, itchy, scaly skin when they come.... The reaction is usually associated with an aller...
...ient in the -- depo medroxyprogesterone acetate or... long term. The younger you are when you begin usi...ne-related problems later in life. // From the ..., our bone mass is constantly breaking down and re...
...with testicular cancer may inadvertently increase ...rs.A research team from North Carolina University ...s go down, a high rise in levels of amyloid – the ...ccurs. They suggest that this phenomenon might exp...
...d if all pregnant women stopped smoking, say Austr...rs need much more support and training in helping ...k of having a low birth weight baby, a miscarriage... SIDS - and if women are not able to give up entir...
Other Medicine News:
(Date:10/7/2008)...Study Showed Larazotide Acetate Prevented Immunolo...atients with Celiac Disease, Additional Data Indic...ase, ORLANDO, Fla., Oct. 7 /- Alba T... clinical studies this week at the American,Colleg... Meeting. Data from,study CLIN 1001-004, the first...
(Date:10/7/2008)... FORT COLLINS, Colo., Oct. 7 /- A st...mining embryonic stem cell self-renewal,reported ...tim (recombinant,human serum albumin) was an effec...l culture., The article entitled, "The ground sta... that researchers used Cellastim as a recombinant,...
(Date:10/7/2008)... BERKELEY, Calif., Oct. 7 /- Aerovan...fety data from a Phase I trial of its Aerovant,inh...with no evidence of,local irritancy following asth...This 10 mg dose will be the highest of three doses...g study, which is scheduled to begin early,next ye...
(Date:10/7/2008)... SAN DIEGO, Oct. 7 /- Arde...ay that a poster entitled "RDEA119, a Potent,and H...Dextran Sulfate,Sodium (DSS) -- induced Chronic Co...ege of Gastroenterology (ACG) 2008 Annual Meeting ...ta from a preclinical study of,RDEA119, the Compan...
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4NeoGenomics to Present at the Noble Financial Equity Conference 25367 1NeoGenomics to Present at the Noble Financial Equity Conference 25367 2Courage Center Seeks Applications for Judd Jacobson Memorial Award 25364 1Courage Center Seeks Applications for Judd Jacobson Memorial Award 25364 2REMOXY 28R 29 NDA Filing Accepted by FDA and Priority Review Granted 2827 1REMOXY 28R 29 NDA Filing Accepted by FDA and Priority Review Granted 2827 2REMOXY 28R 29 NDA Filing Accepted by FDA and Priority Review Granted 2827 3New Test Scans Beef for Mad Cow Disease 25361 1New Test Scans Beef for Mad Cow Disease 25361 2
...ESS WIRE)--Jun 21, 2007 - Opexa,Therapeutics, Inc....ent and commercialization of cell therapies, today... Phase I/II,extension clinical trial of the invest...e sclerosis (MS). In this one-year,8-subject exte...,and secondary progressive (SPMS) subjects, Tovaxi...
...ne 21, 2007 - “In anaplastic,astrocytoma, AP...or,to temozolomide,” Prof. Albert Wong, M.D....d on the international Phase,IIb study with the TG...Antisense Pharma. Prof. Wong discussed the results...central nervous system tumors,at the 43rd Annual M...
Other Medicine Technology:Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 2Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 3Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 4Opexa Therapeutics Reports Positive Top-line Data in Phase I/II,Extension Trial with Tovaxin for Multiple Sclerosis 5Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 3Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 4
...illennium, the newest entry in the Beehive product...monitoring with the technology of the 21st century...igital Video/EEG instrument, providing complete da...that are specialized for epilepsy monitoring appli...
...ncludes 16 electrodes with ball joint, and flexi...r electrode assembly, with 16 female support for b... electrodes. 2 individual electrodes with flexib.... Drill to hole skull. Mounting post. Key to...
Medelec synergy T-EP Developed in collaboration with leading practitioners, for ease of use and an exceptionally high standard of clinical testing, Synergy T-EP harnesses PC Multimedia technology and
Neuropack MEB-2200 evoked potential/EMG measuring system is user friendly Windows NT, Pentium III PC-based EP/EMG measuring system.
Medicine Products: